Publication date: Aug 16, 2026
The COVID-19 pandemic and pandemic response may have long-term consequences. The cumulative impact may be better appraised when post-pandemic years are also considered. For 38 populations with reliable death registration data, we estimated excess deaths for 2020-2025 with 4 models and granular age stratification. The Fa model compared deaths against the mean of 2017-2019. Three other trend models considered changes in mortality rates after 2003 (or after a country reached $20,000 per capita income) factoring trend-of-trends (TTa), including shrinkage (STTa), and factoring also the 2024-2025 data for trend-of-trends calculation (STTa). Slopes (weighted mean -0.58%/year in 2019) and slopes-of-slopes (weighted mean +0.106%/year-squared) for age-stratified mortality rates were highly heterogeneous across populations. On model average, 6 populations (Luxembourg, Ireland, Sweden, New Zealand, Denmark, Korea) had cumulative death deficits during 2020-2025, while another 6 (Chile, Bulgaria, Japan, Greece, USA, Italy) had >4% excess deaths. Differences across populations were more prominent during 2020-2023, while 33/38 countries had estimated death deficits in 2024-2025. Total 2020-2025 excess deaths were 1.16-2.63 million (2020-2023: 2.19-3.03 million; 2024-2025: -1.03 to -0.40 million deficit). Lack of age stratification and use of unchanged linear trends for the baseline grossly biased excess death estimates upwards. Socioeconomically more vulnerable populations had higher pandemic deaths, but a more pronounced post-pandemic death deficit. Excess death estimates require careful consideration of changing population age structure and long-term mortality trajectories. Post-pandemic death deficits, especially in more vulnerable populations, may reflect deaths of people with modest life expectancy during the pandemic with respective pay off in 2024-2025
| Concepts | Keywords |
|---|---|
| Countries | |
| Death | |
| Deaths | |
| Excess | |
| Medrxiv | |
| Models | |
| Mortality | |
| Pandemic | |
| Populations | |
| Post | |
| Preprint | |
| Rates | |
| Stanford | |
| Year | |
| Years |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 pandemic |
| drug | DRUGBANK | Tropicamide |
| disease | MESH | death |
| drug | DRUGBANK | Coenzyme M |
| drug | DRUGBANK | Naproxen |
| disease | MESH | infections |
| disease | MESH | alcohol abuse |